Want to join the conversation?
$GS 2Q15 PR: Net revenues were $9,069MM, down 0.61% from $9,125MM in 2Q14. Net earnings applicable to common shareholders were $916MM, down 53.1% from $1,953MM in 2Q14. 1H15: Net revenues were $19,686MM, up 6.68% from $18,453MM in 1H14. Net earnings applicable to common shareholders were $3,664MM, down 6% from $3,902MM in 1H14.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)